Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy.

Pinto R, Petriella D, Lacalamita R, Montrone M, Catino A, Pizzutilo P, Botticella MA, Zito FA, Del Bene G, Zonno A, Tommasi S, De Summa S.

Cancers (Basel). 2019 Aug 9;11(8). pii: E1145. doi: 10.3390/cancers11081145.

2.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Cortellini A, Leonetti A, Catino A, Pizzutillo P, Ricciuti B, De Giglio A, Chiari R, Bordi P, Santini D, Giusti R, De Tursi M, Brocco D, Zoratto F, Rastelli F, Citarella F, Russano M, Filetti M, Marchetti P, Berardi R, Torniai M, Cortinovis D, Sala E, Maggioni C, Follador A, Macerelli M, Nigro O, Tuzi A, Iacono D, Migliorino MR, Banna G, Porzio G, Cannita K, Ferrara MG, Bria E, Galetta D, Ficorella C, Tiseo M.

Clin Transl Oncol. 2019 Aug 7. doi: 10.1007/s12094-019-02193-w. [Epub ahead of print]

PMID:
31392645
3.

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases.

Cortinovis D, Chiari R, Catino A, Grossi F, DE Marinis F, Sperandi F, Piantedosi F, Vitali M, Parra HJS, Migliorino MR, Tondini C, Tassinari D, Frassoldati A, Verderame F, Pazzola A, Cognetti F, Palmiotti G, Marchetti P, Santoro A, Giannarelli D, Colonese F, Delmonte A.

Anticancer Res. 2019 Aug;39(8):4265-4271. doi: 10.21873/anticanres.13590.

PMID:
31366516
4.

Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?

Longo V, Catino AM, Montrone M, Pesola F, Pizzutilo P, Delbene G, Gatti P, Ferrante A, Galetta D.

J Thorac Oncol. 2019 Aug;14(8):e170-e172. doi: 10.1016/j.jtho.2019.03.010. No abstract available.

PMID:
31345340
5.

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.

Santo A, Pilotto S, Galetta D, Grossi F, Fasola G, Romano G, Bonanno L, Bearz A, Papi M, Roca E, Catino A, Follador A, Rijavec E, Genova C, Petrillo P, Favaretto A, Giannone L, Milella M, Tortora G, Giannarelli D, Bria E; Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer).

Lung Cancer. 2019 Aug;134:121-126. doi: 10.1016/j.lungcan.2019.06.011. Epub 2019 Jun 11.

PMID:
31319970
6.

Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma.

Catino A, de Gennaro G, Di Gilio A, Facchini L, Galetta D, Palmisani J, Porcelli F, Varesano N.

Cancers (Basel). 2019 Jun 14;11(6). pii: E831. doi: 10.3390/cancers11060831. Review.

7.

Tobacco control in Europe: A review of campaign strategies for teenagers and adults.

Bafunno D, Catino A, Lamorgese V, Pizzutilo P, Di Lauro A, Petrillo P, Lapadula V, Mastrandrea A, Ricci D, Galetta D.

Crit Rev Oncol Hematol. 2019 Jun;138:139-147. doi: 10.1016/j.critrevonc.2019.01.022. Epub 2019 Apr 2. Review.

PMID:
31092369
8.

A Change in Focus.

Catino AB, Ryan JJ.

Circ Cardiovasc Imaging. 2019 May;12(5):e009186. doi: 10.1161/CIRCIMAGING.119.009186. No abstract available.

PMID:
31088150
9.

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Scattone A, Catino A, Schirosi L, Caldarola L, Tommasi S, Lacalamita R, Montagna ES, Galetta D, Serio G, Zito FA, Mangia A.

Transl Oncol. 2019 Feb;12(2):389-395. doi: 10.1016/j.tranon.2018.11.006. Epub 2018 Dec 4.

10.

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.

Garassino MC, Crinò L, Catino A, Ardizzoni A, Cortesi E, Cappuzzo F, Bordi P, Calabrò L, Barbieri F, Santo A, Altavilla G, Ambrosio F, Mini E, Vasile E, Morgillo F, Scoppola A, Bengala C, Follador A, Tedde N, Giannarelli D, Lo Russo G, Vitiello F.

Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047.

PMID:
30486741
11.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

PMID:
30249391
12.

Breast Metastasis from Malignant Pleural Mesothelioma: A Rare Challenging Entity.

Catino A, La Forgia D, Scattone A, Dentamaro R, Lapadula V, Galetta D.

J Thorac Oncol. 2018 Jul;13(7):e117-e118. doi: 10.1016/j.jtho.2018.02.028. No abstract available.

13.

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.

Catino AB, Hubbard RA, Chirinos JA, Townsend R, Keefe S, Haas NB, Puzanov I, Fang JC, Agarwal N, Hyman D, Smith AM, Gordon M, Plappert T, Englefield V, Narayan V, Ewer S, ElAmm C, Lenihan D, Ky B.

Circ Heart Fail. 2018 Mar;11(3):e004408. doi: 10.1161/CIRCHEARTFAILURE.117.004408.

14.

Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study.

Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007117. doi: 10.1161/CIRCIMAGING.117.007117.

15.

Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.

Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos SG.

Eur J Heart Fail. 2018 Jan;20(1):164-174. doi: 10.1002/ejhf.1018. Epub 2017 Nov 1.

16.

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

Gobbini E, Galetta D, Tiseo M, Graziano P, Rossi A, Bria E, Di Maio M, Rossi G, Gregorc V, Riccardi F, Scotti V, Ceribelli A, Buffoni L, Delmonte A, Franchina T, Migliorino MR, Cortinovis D, Pisconti S, Bordi P, Catino A, Maiello E, Arizio F, Novello S; other Co-Authors.

Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.

PMID:
28838394
17.

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease.

Capelletto E, Rapetti SG, Demichelis S, Galetta D, Catino A, Ricci D, Moretti AM, Bria E, Pilotto S, Bruno A, Valmadre G, Bandelli GP, Trisolini R, Gianetta M, Pacchiana MV, Vallone S, Novello S.

Clin Respir J. 2018 Mar;12(3):1150-1159. doi: 10.1111/crj.12644. Epub 2017 May 10.

PMID:
28466511
18.

Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.

Narayan V, Keefe S, Haas N, Wang L, Puzanov I, Putt M, Catino A, Fang J, Agarwal N, Hyman D, Smith AM, Finkelman BS, Narayan HK, Ewer S, ElAmm C, Lenihan D, Ky B.

Clin Cancer Res. 2017 Jul 15;23(14):3601-3609. doi: 10.1158/1078-0432.CCR-16-2869. Epub 2017 Feb 14.

19.

Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.

Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos SG.

J Am Coll Cardiol. 2016 Oct 18;68(16):1741-1752. doi: 10.1016/j.jacc.2016.07.756.

20.

Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A review.

Daniele A, Abbate I, Oakley C, Casamassima P, Savino E, Casamassima A, Sciortino G, Fazio V, Gadaleta-Caldarola G, Catino A, Giotta F, De Luca R, Divella R.

Int J Biochem Cell Biol. 2016 Aug;77(Pt A):91-101. doi: 10.1016/j.biocel.2016.06.002. Epub 2016 Jun 4.

PMID:
27267661
21.

Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow.

Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos SG.

JACC Heart Fail. 2016 Jul;4(7):570-576. doi: 10.1016/j.jchf.2016.02.015. Epub 2016 May 11.

22.

Metachronous primary uterine cancer surgically resected during Crizotinib treatment in a ALK-rearranged advanced lung adenocarcinoma.

Catino A, Misino A, Scattone A, Caldarola L, Petroni S, Logroscino A, Montagna ES, Serio G, Simone G, Galetta D.

Transl Lung Cancer Res. 2016 Feb;5(1):145-9. doi: 10.3978/j.issn.2218-6751.2016.01.04.

23.

Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target.

Galetta D, Catino A, Misino A.

Transl Lung Cancer Res. 2016 Feb;5(1):143-4. doi: 10.3978/j.issn.2218-6751.2016.01.09. No abstract available.

24.

miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.

Petriella D, De Summa S, Lacalamita R, Galetta D, Catino A, Logroscino AF, Palumbo O, Carella M, Zito FA, Simone G, Tommasi S.

Tumour Biol. 2016 Apr;37(4):5503-13. doi: 10.1007/s13277-015-4391-1. Epub 2015 Nov 13.

PMID:
26566629
25.

Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease.

Galetta D, Catino A, Misino A, Logroscino A, Fico M.

Tumori. 2016 Mar-Apr;102(2):127-30. doi: 10.5301/tj.5000364. Epub 2015 Jun 5. Review.

PMID:
26108245
26.

Bladder and gastric metastases from lung adenocarcinoma harboring codon 13 KRAS mutation: a case report with unusual clinical outcome.

Galetta D, Catino A, Misino A, De Ceglie A, Logroscino A, Simone G, Natalicchio MI.

Tumori. 2015 Sep 9;101(5):e138-40. doi: 10.5301/tj.5000358.

PMID:
26045124
27.

Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.

Mangia A, Partipilo G, Schirosi L, Saponaro C, Galetta D, Catino A, Scattone A, Simone G.

Mol Biotechnol. 2015 Jun;57(6):549-57. doi: 10.1007/s12033-015-9848-3.

PMID:
25744438
28.

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.

Galetta D, Cinieri S, Pisconti S, Gebbia V, Morabito A, Borsellino N, Maiello E, Febbraro A, Catino A, Rizzo P, Montrone M, Misino A, Logroscino A, Rizzi D, Di Maio M, Colucci G.

Clin Lung Cancer. 2015 Jul;16(4):262-73. doi: 10.1016/j.cllc.2014.12.002. Epub 2014 Dec 9.

29.

Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG.

J Am Coll Cardiol. 2014 Oct 14;64(15):1602-12. doi: 10.1016/j.jacc.2014.05.073.

30.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

Landi L, Tiseo M, Chiari R, Ricciardi S, Rossi E, Galetta D, Novello S, Milella M, D'Incecco A, Minuti G, Tibaldi C, Salvini J, Facchinetti F, Haspinger ER, Cortinovis D, Santo A, Banna G, Catino A, GiajLevra M, Crinò L, de Marinis F, Cappuzzo F.

Clin Lung Cancer. 2014 Nov;15(6):411-417.e4. doi: 10.1016/j.cllc.2014.07.002. Epub 2014 Aug 16.

31.

Approach to the tricyclic core of the tigliane-daphnane diterpenes. Concerning the utility of transannular aldol additions.

Catino AJ, Sherlock A, Shieh P, Wzorek JS, Evans DA.

Org Lett. 2013 Jul 5;15(13):3330-3. doi: 10.1021/ol401367h. Epub 2013 Jun 20.

PMID:
23786521
32.

Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin.

Galetta D, Silvestris N, Catino A, Colucci G.

J Thorac Oncol. 2011 Nov;6(11):1964. doi: 10.1097/JTO.0b013e3182333f34. No abstract available.

33.
34.

Single-step therapy -- feasibility and safety of simultaneous transarterial chemoembolization and radiofrequency ablation for hepatic malignancies.

Gadaleta C, Catino A, Ranieri G, Fazio V, Gadaleta-Caldarola G, Cramarossa A, Armenise F, Canniello E, Vinciarelli G, Laricchia G, Mattioli V.

In Vivo. 2009 Sep-Oct;23(5):813-20.

35.

VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.

Patruno R, Arpaia N, Gadaleta CD, Passantino L, Zizzo N, Misino A, Lucarelli NM, Catino A, Valerio P, Ribatti D, Ranieri G.

J Cell Mol Med. 2009 Mar;13(3):555-61. doi: 10.1111/j.1582-4934.2008.00355.x. Epub 2008 Apr 18.

36.

Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.

Massidda B, Atzori F, Scanu A, Contu A, Farris A, Catino AM, Palmeri S, Minerba L, Ionta MT.

Oncology. 2007;72(1-2):17-26. Epub 2007 Nov 12.

PMID:
17998786
37.
38.

Radiofrequency thermal ablation in the treatment of lung malignancies.

Gadaleta C, Catino A, Mattioli V.

In Vivo. 2006 Nov-Dec;20(6A):765-7.

39.
40.

The oxidative mannich reaction catalyzed by dirhodium caprolactamate.

Catino AJ, Nichols JM, Nettles BJ, Doyle MP.

J Am Chem Soc. 2006 May 3;128(17):5648-9.

41.

Benzylic oxidation catalyzed by dirhodium(II,III) caprolactamate.

Catino AJ, Nichols JM, Choi H, Gottipamula S, Doyle MP.

Org Lett. 2005 Nov 10;7(23):5167-70.

PMID:
16268529
42.

Efficient aziridination of olefins catalyzed by mixed-valent dirhodium(II,III) caprolactamate.

Catino AJ, Nichols JM, Forslund RE, Doyle MP.

Org Lett. 2005 Jun 23;7(13):2787-90.

PMID:
15957947
43.

Radiofrequency thermal ablation of 69 lung neoplasms.

Gadaleta C, Catino A, Ranieri G, Armenise F, Colucci G, Lorusso V, Cramarossa A, Fiorentini G, Mattioli V.

J Chemother. 2004 Nov;16 Suppl 5:86-9.

PMID:
15675488
44.

Serum vascular endothelial growth factor concentrations in hepatocellular cancer patients undergoing percutaneously radiofrequency thermal ablation.

Gadaleta C, Coviello M, Catino A, Venneri MT, Stea B, Quaranta M, Mattioli V, Ranieri G.

J Chemother. 2004 Nov;16 Suppl 5:7-10.

PMID:
15675467
45.

Dirhodium(II) caprolactamate: an exceptional catalyst for allylic oxidation.

Catino AJ, Forslund RE, Doyle MP.

J Am Chem Soc. 2004 Oct 27;126(42):13622-3.

PMID:
15493912
46.

Radiofrequency ablation of 40 lung neoplasms: preliminary results.

Gadaleta C, Mattioli V, Colucci G, Cramarossa A, Lorusso V, Canniello E, Timurian A, Ranieri G, Fiorentini G, De Lena M, Catino A.

AJR Am J Roentgenol. 2004 Aug;183(2):361-8.

PMID:
15269026
47.

The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy.

Ranieri G, Passantino L, Patruno R, Passantino G, Jirillo F, Catino A, Mattioli V, Gadaleta C, Ribatti D.

Oncol Rep. 2003 Sep-Oct;10(5):1189-93.

PMID:
12883679
48.

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.

Lorusso V, Crucitta E, Silvestris N, Catino A, Caporusso L, Mazzei A, Guida M, Latorre A, Sambiasi D, D'Amico C, Schittulli F, Calabrese P, De Lena M.

Br J Cancer. 2003 Feb 24;88(4):491-5.

49.

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin.

Catino A, Crucitta E, Latorre A, Sambiasi D, Calabrese P, Lorusso V.

Oncol Rep. 2003 Jan-Feb;10(1):163-7.

PMID:
12469164
50.

Epithelial ovarian cancer: second and third line chemotherapy (review).

Latorre A, De Lena M, Catino A, Crucitta E, Sambiasi D, Guida M, Misino A, Lorusso V.

Int J Oncol. 2002 Jul;21(1):179-86. Review.

PMID:
12063566

Supplemental Content

Loading ...
Support Center